ARTICLE SUMMARY:
Mark Turco reflects on what he has learned at each stop in his career and offers advice for physicians considering a move from clinical practice into the medtech industry, along with insights from his time in the transcatheter valve business and his new role in developing the life sciences sector in New England.
Mark Turco, MD, began his journey in medicine as a cardiovascular interventionalist in the Philadelphia area and spent a decade leading cardiovascular research with Adventist Health near Washington, DC, before joining Covidien in 2011 as its chief medical officer for vascular therapies.
